Cernostics
Pittsburgh, PA
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.
cernostics.comCompany Details
Founded
- 2008
Employees
- Between 10 - 50 employees
Raised
- $21,260,848
Headquarters Location
- Pittsburgh, PA
Public
- No
Acquired
- Yes
CEO
Mike Hoerres
Founders
- Rebecca Critchley-Thorne
Company Collections
These are collections Cernostics is a part of. Click on the collection name to view similar companies.
Cernostics' Industries
Company Collections For Cernostics
Cernostics Headquarters Location
Total Amount Raised: $21,260,848
Cernostics Funding Rounds
Series Unknown
$5,981,569
Series A
$2,500,000
Series A Investors
Illumina VenturesSeries Unknown
$5,000,000
Series Unknown Investors
UPMCNovitas CapitalSeries Unknown
$1,962,678
Series Unknown Investors
Ben Franklin Technology Partners of Northeastern PennsylvaniaSeries B
$1,400,000
Series B Investors
Novitas CapitalPittsburgh Life Sciences GreenhouseGeisingerSeries Unknown
$1,423,000
Series Unknown Investors
Novitas CapitalSeries A
$2,600,000
Series A Investors
Novitas CapitalPittsburgh Life Sciences GreenhouseGeisinger VenturesDebt Financing
$393,600
Cernostics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Cernostics.